Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

Lower dose EURneffy® nasal adrenaline spray approved by MHRA for younger children 30th June 2026

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four years and over. This adrenaline device option is
[…]

Read more
Anaphylaxis UK welcomes launch of Natasha’s Prize 22nd June 2026

The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community.  As a charity supporting people living with serious allergies, Anaphylaxis UK warmly
[…]

Read more
NICE publishes updated anaphylaxis guidelines on assessment and referral after emergency treatment 18th June 2026

The National Institute for Health and Care Excellence (NICE) has published updated guidance on the assessment and referral of people following emergency treatment for anaphylaxis. This new guideline replaces NICE guideline CG134 (December 2011).  The update aims to improve the
[…]

Read more

News Type:

LEAP study finds peanut consumption can protect infants at risk of developing peanut allergy 20th July 2015

Peanut allergy, which affects 1 in 50 children in the UK, is one of the most high risk allergens, alongside tree nuts, milk and egg. However, a new study of peanut allergy in those aged 4-11 months has noted that

Read more
FSA Statement about Cumin Swap 20th July 2015

Last week The FSA  issued an alert to people with nut allergies about a batch of ground cumin sold by The Barts Ingredients Company Ltd which was found to contain traces of almond protein not listed on the label. The

Read more
Anaphylaxis Campaign statement on link between anticholinergic antihistamine and dementia 20th July 2015

Statement regarding recent study linking commonly used medicines, including over-the-counter anticholinergic antihistamine treatments for conditions such as hay-fever, to dementia. A recent study found there may be a link between commonly used medicines, including some first-generation antihistamines, and dementia. The BBC

Read more
Preventing harm to people with drug allergies – New NICE guidelines September 2014 20th July 2015

Every year, around 62,000 people in England have a serious allergic reaction to a drug which puts them in hospital. NICE has published its first guideline on drug allergy in adults, children and young people, which aims to dispel confusion

Read more
London reception marks 20 Years of the Anaphylaxis Campaign – Monday 8th September 2014 20th July 2015

The event held at Governors’ Hall, St Thomas’ Hospital highlighted the Charity’s achievements over the last 20 years and honoured instrumental figures in accomplishing important milestones, such as changes to food labelling and the establishment of many of the UK’s

Read more
Prescription Charges Coalition responds to the Barker Commission Recommendations on Prescription Charges 20th July 2015

The Prescription Charges Coalition has issued a statement in response to proposals from the Barker Commission which recommend some fundamental changes to prescription charges in order to raise a potential additional £1 billion revenue for the NHS. These include the

Read more
Spare Pens in Schools: the Anaphylaxis Campaign launches campaign to ensure adrenaline is stocked in all state schools 20th July 2015

Today, 4th November 2014, we have launched an important new initiative for our schools. If successful, this campaign will ensure every state school, pre-school and nursery have a stock of Adrenaline Auto-Injectors and there are sufficient trained staff to operate

Read more
The Anaphylaxis Campaign welcomes the results of the FSA?s survey on ?May Contain? labelling which was published today (4th November 2014). 20th July 2015

Overall the results were very positive and cross contamination appears to be well controlled by manufacturers. On the rare occasion cross contamination did occur the products were marked up with a precautionary label.  This supports our advice that allergic consumers

Read more